198 related articles for article (PubMed ID: 6157747)
1. Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity.
Ortaldo JR; Phillips W; Wasserman K; Herberman RB
J Immunol; 1980 Oct; 125(4):1839-44. PubMed ID: 6157747
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phytohaemagglutinin-induced autorosette formation of human peripheral blood lymphocytes by RNA or protein synthesis inhibitor.
Hyodo S; Kishi T; Kittaka E; Suzawa T; Tanabe A; Tanaka Y; Sakano T; Usui T
Clin Exp Immunol; 1983 Jul; 53(1):140-4. PubMed ID: 6191894
[TBL] [Abstract][Full Text] [Related]
4. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
[TBL] [Abstract][Full Text] [Related]
5. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
6. Increased cell-mediated lysis of chicken erythrocytes following the addition of metabolic inhibitors.
Moody CE; Tunticharoen M; Laux DC
Immunology; 1977 Sep; 33(3):285-93. PubMed ID: 409663
[TBL] [Abstract][Full Text] [Related]
7. Reevaluation of the role of de novo protein synthesis in rat thymocyte apoptosis.
Chow SC; Peters I; Orrenius S
Exp Cell Res; 1995 Jan; 216(1):149-59. PubMed ID: 7813615
[TBL] [Abstract][Full Text] [Related]
8. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
9. Metabolic requirements for the in vitro augmentation of mouse natural killer activity by interferon.
Djeu JY; Stocks N; Varesio L; Holden HT; Herberman RB
Cell Immunol; 1981 Feb; 58(1):49-60. PubMed ID: 6164493
[No Abstract] [Full Text] [Related]
10. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
Nair MP; Schwartz SA
J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
12. Active tumor cell resistance to human natural killer lymphocyte attack.
Hudig D; Djobadze M; Redelman D; Mendelsohn J
Cancer Res; 1981 Jul; 41(7):2803-8. PubMed ID: 7248944
[TBL] [Abstract][Full Text] [Related]
13. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of puromycin-induced apoptosis in breast cancer cells by IGF-I occurs simultaneously with increased protein synthesis.
Söderlund G; Haarhaus M; Chisalita S; Arnqvist HJ
Neoplasma; 2004; 51(1):1-11. PubMed ID: 15004651
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of human natural killer cells by interferon requires RNA and protein synthesis.
Bishop GA; Schwartz SA
Clin Immunol Immunopathol; 1982 Dec; 25(3):374-85. PubMed ID: 6186424
[No Abstract] [Full Text] [Related]
16. Sequential irreversible, actinomycin D-sensitive, and cycloheximide-sensitive steps prior to cortisol inhibition of uridine utilization by P1798 tumor lymphocytes.
Stevens J; Stevens YW
Cancer Res; 1975 Aug; 35(8):2145-53. PubMed ID: 1149029
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 2 dependence of human natural killer (NK) cell activity.
Domzig W; Stadler BM; Herberman RB
J Immunol; 1983 Apr; 130(4):1970-3. PubMed ID: 6601144
[TBL] [Abstract][Full Text] [Related]
18. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
19. 2',5'-Oligoadenylate trimer core and the cordycepin analog augment the tumoricidal activity of human natural killer cells.
Black PL; Henderson EE; Pfleiderer W; Charubala R; Suhadolnik RJ
J Immunol; 1984 Nov; 133(5):2773-7. PubMed ID: 6332860
[TBL] [Abstract][Full Text] [Related]
20. In vitro boost of human NK activity by a triethylphosphine gold derivative.
Russell AS; Nakashima S; Miller C
Clin Exp Immunol; 1984 Jul; 57(1):207-10. PubMed ID: 6204799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
